Starling Oncology (STLN) Cash & Equivalents Growth (1y) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Cash & Equivalents Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 7.88% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | -17.33% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 8.68% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | -5.57% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 0.88% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | -27.93% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -83.91% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | -44.10% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 113.93% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 35.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.66% |
| Mar 31, 2026 | -23.80% |
| Dec 31, 2025 | -32.42% |
| Sep 30, 2025 | -41.65% |
| Jun 30, 2025 | -16.84% |
| Mar 31, 2025 | 10.22% |
| Dec 31, 2024 | 48.32% |
| Sep 30, 2024 | 72.15% |
| Jun 30, 2024 | 26.07% |
| Mar 31, 2024 | 136.43% |
| Dec 31, 2023 | 139.03% |
| Sep 30, 2023 | -55.17% |
| Jun 30, 2023 | -55.00% |
| Mar 31, 2023 | -84.04% |
| Dec 31, 2022 | -87.84% |
| Sep 30, 2022 | 432.65% |
| Jun 30, 2022 | 323.28% |
| Mar 31, 2022 | 248.51% |
| Dec 31, 2021 | 1,820.21% |
| Sep 30, 2021 | 1,054.85% |